News

The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.
B oth men and women with psoriasis are equally at risk for developing psoriatic arthritis (PsA)-a chronic inflammatory ...
Lyme disease is a complex condition with a long history of misdiagnosis, and Lyme arthritis, a late manifestation of the ...